Cargando…

Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patients

Breast cancer (BC) is the most common malignancy worldwide and neoadjuvant therapy (NAT) plays an important role in the treatment of patients with early BC. However, only a subset of BC patients can achieve pathological complete response (pCR) and benefit from NAT. It is therefore necessary to predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jian, Hao, Li, Qian, Xiaojun, Lin, Lin, Pan, Yueyin, Han, Xinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352856/ https://www.ncbi.nlm.nih.gov/pubmed/35935976 http://dx.doi.org/10.3389/fimmu.2022.948601

Ejemplares similares

An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer
por: Fu, Changfang, et al.
Publicado: (2021)

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
por: Dong, Jie, et al.
Publicado: (2021)

An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas
por: Chen, Jian, et al.
Publicado: (2021)

Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning
por: Wec, Anna Z., et al.
Publicado: (2021)

Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI
por: Lu, Nannan, et al.
Publicado: (2021)

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
por: Pérez-Pena, Javier, et al.
Publicado: (2019)

Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis
por: Zhou, Qiong, et al.
Publicado: (2021)

The single-atom iron nanozyme mimicking peroxidase remodels energy metabolism and tumor immune landscape for synergistic chemodynamic therapy and photothermal therapy of triple-negative breast cancer
por: Qian, Xiaojun, et al.
Publicado: (2022)

Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer
por: Dong, Menghao, et al.
Publicado: (2022)

Association between platelet-to-lymphocyte ratio and outcomes in HER2-positive advanced breast cancer patients treated with pyrotinib: a retrospective study
por: Hao, Li, et al.
Publicado: (2023)

Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
por: Lin, Guang-Tan, et al.
Publicado: (2022)

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
por: Saraiva, Diana P., et al.
Publicado: (2018)

Construction and systematic evaluation of a machine learning-based cuproptosis-related lncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma
por: Lu, Dingyu, et al.
Publicado: (2023)

Editorial: Immunology of machine perfused organs and tissues
por: Hautz, Theresa, et al.
Publicado: (2022)

Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy
por: Xu, Lin-Lin, et al.
Publicado: (2023)

Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastoma
por: Li, Wen, et al.
Publicado: (2023)

Metabolomics by NMR Combined with Machine Learning to Predict Neoadjuvant Chemotherapy Response for Breast Cancer
por: Cardoso, Marcella R., et al.
Publicado: (2022)

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
por: Zhang, Jinguo, et al.
Publicado: (2023)

Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis
por: Qin, Hao, et al.
Publicado: (2023)

Combining Immune-Related Genes For Delineating the Extracellular Matrix and Predicting Hormone Therapy and Neoadjuvant Chemotherapy Benefits In Breast Cancer
por: Liu, Jianyu, et al.
Publicado: (2022)

Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
por: Zhang, Jinguo, et al.
Publicado: (2022)

A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
por: Chen, Zihao, et al.
Publicado: (2021)

Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods
por: Zhou, Tianyang, et al.
Publicado: (2022)

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning
por: Gong, Li, et al.
Publicado: (2023)

Machine Perfusion of Extended Criteria Donor Organs: Immunological Aspects
por: Kvietkauskas, Mindaugas, et al.
Publicado: (2020)

Predictive Immunological Markers in Oncology
por: Jäger, Dirk, et al.
Publicado: (2012)

Machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy
por: Lo Gullo, Roberto, et al.
Publicado: (2019)

Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning
por: Wiffen, Laura, et al.
Publicado: (2023)

A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses
por: Li, Jia, et al.
Publicado: (2022)

Editorial: Osteoarticular-immunological interplay in response to disease and therapy
por: Deloch, Lisa, et al.
Publicado: (2022)

Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach
por: Yu, Hao, et al.
Publicado: (2022)

Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound
por: Zhang, Hao, et al.
Publicado: (2023)

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms
por: Liu, Zhichao, et al.
Publicado: (2022)

Predicting Pathological Complete Response in Neoadjuvant Dual Blockade With Trastuzumab and Pertuzumab in HER2 Gene Amplified Breast Cancer
por: Xiao, Yi, et al.
Publicado: (2022)

Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease
por: Ness, Sara, et al.
Publicado: (2021)

Identification of immune microenvironment subtypes and signature genes for Alzheimer’s disease diagnosis and risk prediction based on explainable machine learning
por: Lai, Yongxing, et al.
Publicado: (2022)

The Immunology of Hormone Receptor Positive Breast Cancer
por: Goldberg, Jonathan, et al.
Publicado: (2021)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m06r03mliicrbd90kdsliomoba